# Axis 3 — prompt for the second blind reviewer

> Recorded before the run, so the question cannot be adjusted to the answer.
>
> **Read this section before reading the result.** Half of what this round can measure is
> worthless if the two parts of the set are read as one.

---

## What this round can and cannot establish

The reference derivation was repaired using the first blind reviewer's diagnosis. Three of
the eleven anchors were changed on the strength of what that reviewer said:

| Anchor | Change | Driven by round 1 |
|---|---|---|
| `CLAIM 035 \| Summary \| sent[1]` | 1 → 3 propositions | three `ABSENT` verdicts against the reference |
| `CLAIM 024 \| Precisazione \| sent[1]` | 1 → 2 propositions | a `SPLIT` verdict against the reference |
| `CLAIM 035 \| Summary \| sent[3]` | proposition restated | *"'GSK3β output falls' is an interpretation"* |

**At those three anchors, agreement in round 2 is close to circular.** One side was edited to
resemble the other, so a second reviewer finding them alike confirms that the edit landed —
not that it was right. Discount it.

**The eight untouched anchors carry the signal**, and they carry two different ones:

1. **Inter-rater reliability.** Two independent reviewers judging the same unchanged pairs
   should reach the same verdicts. If they do not, the human step is unreliable and every
   conclusion resting on round 1 — including the repairs — is weaker than it looks.
2. **Whether the repair over-corrected.** Anchor 8 now has three propositions on each side.
   Whether they are the *same* three is a question only a fresh reader can answer, and a
   verdict of `DIFFERENT` there would mean the fix traded an under-split for a mismatch.

The reviewer is told none of this. Naming the repaired anchors would tell it where agreement
is expected, which is the one thing it must not know.

**New shuffle, new seed** (`20260805`): the α/β mapping differs from round 1, so the two
replies cannot be aligned by label and my knowledge of the first mapping does not carry over.

## Residual tells, again

Only the transformations declared non-semantic in canonicalisation v1 were applied, plus
`stabilizes → stabilises` this time, since that spelling split was a tell in round 1. What
remains: `uM` appears on one side at anchor 6, and one side consistently names the
experimental system and the mutant control. Blinding removes the label, not the style.

---

```text
You are reviewing pairs of scientific assertions for semantic equivalence.

CONTEXT
Two independent readers were each given the same set of summary sentences about
WWOX (a human gene) from a curated research database. Each reader decomposed those
sentences into atomic assertions in their own words. I need to know, sentence by
sentence, whether the two readers ended up asserting the same things.

The two readers are labelled α and β. The labelling is randomised separately at
every anchor: α at anchor 3 is not the same reader as α at anchor 7. Do not try to
track a reader across anchors; judge each anchor on its own.

YOUR TASK
For each of the 11 anchors below, compare the α propositions with the β
propositions and assign every proposition one verdict:

  SAME       — the same fact, stated in different words
  SUBSUMED   — contained in a proposition on the other side that also says more
  SUBSUMES   — contains a proposition on the other side and says more
  SPLIT      — corresponds to two or more propositions on the other side, together
  DIFFERENT  — not the same assertion, whatever the surface similarity
  ABSENT     — no counterpart on the other side

SUBSUMED and SUBSUMES are a pair: if you judge that one proposition contains
another, label both ends. Do not record a containment as a disagreement.

Also record, per anchor, whether the SPLIT ITSELF agrees: did both readers cut the
sentence into the same number of assertions, regardless of wording?

TWO ERRORS TO AVOID, IN OPPOSITE DIRECTIONS
1. Near-identical wording is not agreement. "inhibits Tau phosphorylation" and
   "inhibits GSK3β-dependent Tau phosphorylation" differ by an attribution: the
   second says which kinase does it. Qualifiers, named controls, mutants, species,
   experimental systems and negations are part of the assertion.
2. Different wording is not disagreement. Two sentences may carry exactly the same
   fact with different word order, different verbs, or one naming a quantity the
   other omits without contradicting it.

When you are genuinely unsure, say UNSURE and state what would settle it. A wrong
confident verdict is worse than a marked uncertainty.

OUTPUT
A markdown table with columns: id | verdict | one-line justification.
Then a second table: anchor | split agrees (yes/no) | note.
Then the tally of each verdict.
No preamble.

═══════════════════════════════════════════════════════════════════════
ANCHOR 1
α1  WWOX directly binds GSK3β through its ADH/SDR domain, using the 388-407 region with L404 required for binding
α2  WWOX binding inhibits GSK3β kinase activity toward Tau
β1  WWOX amino acids 388-407 are required for the interaction with GSK3β

ANCHOR 2
α3  Loss of WWOX can be interpreted as de-repressing GSK3β by removing a direct physical inhibitor
β2  Reducing WWOX raises GSK3β output on Tau, consistent with de-repression rather than a level change

ANCHOR 3
α4  In Wwox-null mice GSK3β is elevated in cortex, hippocampus and cerebellum
α5  Lithium suppresses PTZ-induced seizure susceptibility in the Wwox-null mouse
β3  GSK3β abundance is elevated in cortex, hippocampus, and cerebellum of Wwox-null mice
β4  Lithium significantly suppresses PTZ-induced seizure susceptibility in Wwox-null mice

ANCHOR 4
α6  WW2 engages a second PPxY motif directly when sequence, spacing, linker and orientation create a compatible topology
β5  WW2 pre-orders and stabilises the otherwise unstable WW1 domain
β6  WW2 can directly engage a second PPxY motif when a dual-motif peptide presents a compatible sequence, spacing, linker, and orientation

ANCHOR 5
α7  The largest direct WW2 contribution was observed with engineered tandem peptides using a short polyglycine linker
α8  Native ErbB4 PY1PY2 gains tandem-domain affinity but binds predominantly through WW1, with only very weak apparent WW2 affinity
β7  The strongest direct WW2 engagement requires a short engineered linker
β8  Native ErbB4 PY1PY2 remains predominantly bound through WW1, unlike the engineered short-linker peptides

ANCHOR 6
α9   Isolated WWOX WW2 has no measurable binding to a single PPxY peptide
α10  WW2 stabilises the otherwise unstable WW1 domain within the WWOX tandem WW1-WW2 construct
β9   WW2 lacks significant inherent affinity for the ErbB4 PY3 motif, yet the tandem domain binds PY3 more strongly than isolated WW1 (30 vs 78 uM)
β10  WW2 stabilises the otherwise unstable WW1 domain

ANCHOR 7
α11  WWOX amino acids 388-407 are required for the interaction with GSK3β
α12  WWOX 388-412 contains the FXXXLI/VXRLE motif conserved in GSKIP, Axin and FRAT
α13  L404 is strictly required for the WWOX-GSK3β interaction
β11  WWOX binds GSK3β through its ADH/SDR domain
β12  WWOX residues 388-407 are required for binding GSK3β and are similar to Axin/FRAT/GSKIP GSK3β-binding motifs
β13  WWOX L404 is required for GSK3β binding, whereas the nearby L311 control is not

ANCHOR 8
α14  WWOX inhibits Tau phosphorylation at S396 and S404 but not at the MKK4 site S422
α15  WWOX restores the ability of Tau to promote microtubule assembly, and the GSK3β-binding-deficient L404A does not
α16  WWOX promotes retinoic-acid-induced differentiation of SH-SY5Y cells, and the L404A mutation abolishes the increase
β14  WT WWOX, but not L404A, inhibits GSK3β-dependent Tau phosphorylation at S396 and S404 without affecting S422
β15  WT WWOX, but not GSK3β-binding-deficient L404A, restores Tau-dependent microtubule assembly impaired by GSK3β
β16  WT WWOX promotes RA-induced neurite outgrowth in SH-SY5Y cells, and the effect is abolished by L404A

ANCHOR 9
α17  The WWOX-GSK3β interaction is detectable between endogenous proteins in mouse brain
β17  Endogenous WWOX and GSK3β reciprocally co-immunoprecipitate from mouse brain extract

ANCHOR 10
α18  During RA-induced SH-SY5Y differentiation, phospho-GSK3β S9 remains unchanged while WWOX rises and Tau S396/S404 phosphorylation falls
β18  Phospho-GSK3β-S9 is unchanged while Tau phosphorylation at S396 and S404 falls

ANCHOR 11
α19  Tau knockdown abolishes the neurite-outgrowth increase caused by either WWOX overexpression or GSK3β knockdown
α20  WWOX overexpression and GSK3β knockdown are non-additive, supporting a linear WWOX-GSK3β-Tau pathway with Tau as effector
β19  Tau knockdown abolishes the WWOX effect, and WWOX with siRNA-GSK3β is non-additive
β20  WWOX, GSK3β and Tau lie on one linear pathway with Tau as the effector
═══════════════════════════════════════════════════════════════════════
```

---

## How to read the reply

| Question | Where the answer is |
|---|---|
| Is the human step reliable? | The **8 untouched anchors** — 1, 2, 3, 4, 6, 7, 9, 11. Compare verdict-for-verdict with round 1 |
| Did the repair over-correct? | **Anchor 8**, and secondarily 5 and 10. `SAME` × 3 at anchor 8 means the split now matches; any `DIFFERENT` there means the three assertions do not correspond |
| Did split agreement really improve? | Compare the per-anchor table with round 1's, on the untouched anchors only |

**A trap to expect.** If round 2 reports higher overall agreement, that is the *expected*
consequence of having edited three anchors and proves nothing on its own. The number worth
reading is agreement on the eight anchors nobody touched.

**A result that would be bad news.** Substantial disagreement between round 1 and round 2 on
the untouched anchors. It would mean the human step has poor inter-rater reliability, and
that the repairs were made on one reader's opinion rather than on a measurement.

## Related

[`dismech_axis3_blind_reviewer_prompt.md`](dismech_axis3_blind_reviewer_prompt.md) (round 1) · [`dismech_axis3_review_result.md`](dismech_axis3_review_result.md) · [`data/dismech_axis3_review_raw_reply.md`](data/)
